Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained

MYPI1992002180A0Inactive Publication Date: 1993-06-02MERIAL SAS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1992002180
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1991-12-02
Filing Date
1992-11-27
Publication Date
1993-06-02
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

THE MEDICINAL PRODUCT COMPRISES AS ACTIVE PRINCIPLE A MELARSOMINE HYDROCHLORIDE PREPARATION HAVING A PURITY OF BETWEEN 98.5 AND 100THE PROCESS FOR OBTAINING THIS PREPARATION IS STATED ESSENTIALLY AS FOLLOWS: - STEP 1, TRICHLOROTRIAZINE (TCT) IS CONVERTED TO DIAMINOCHLOROTRIAZINE (DCT) IN AN AMMONIACAL MEDIUM; - STEP 2, THE DCT IS CONVERTED TO MELARSEN ACID HYDROCHLORIDE (MAH) IN THE PRESENCE OF ARSANILIC ACID; - STEP 3, THE MAH IS REDUCED TO MELARSEN OXIDE DIHYDRATE; AND - STEP 4, THE MELARSEN OXIDE DIHYDRATE IS CONVERTED TO MELARSOMINE DIHYDROCHLORIDE IN THE PRESENCE OF CYSTEAMINE HYDROCHLORIDE. IN EACH STEP, A PURIFIED PREPARATION OF THE CORRESPONDING INTERMEDIATE PRODUCT, OR FINAL PRODUCT IN STEP 4, IS OBTAINED.
Need to check novelty before this filing date? Find Prior Art